Peptcell Limited, based in London, specializes in the development of innovative peptide-based therapeutics and delivery systems. The company focuses on harnessing the unique properties of peptides to create solutions for various medical applications, including targeted drug delivery and therapeutic interventions. With a commitment to advancing healthcare, Peptcell is engaged in cutting-edge research aimed at improving patient outcomes through the application of peptide technology in pharmaceuticals and biotechnology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#232 in London

#1,184 in United Kingdom

#39,959 in the World

London, United Kingdom

Peptcell Limited

Forward Citations = 37

7 inventors:

Gregory Alan Stoloff (14 out of 43 patents)

Wilson Romero Caparros-Wanderley (10 out of 28 patents)

Wilson Romero Caparros-Wanderlay (3 out of 3 patents)

4. Olga Pleguezuelos Mateo (1 out of 12 patents)

5. Wilson Caparrós-Wanderley (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Peptcell Limited. Retrieved from https://idiyas.com/company/peptcell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

8 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]